NextCell Pharma AB

ISIN SE0009888795Filings at the FI

At a glance

Most recent filing on August 23, 2018 — an option exercise by Niclas Löwgren on Aug 23, 2018.

We hold 3 visible filings, going back to August 23, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

All 3 shown

  • Niclas Löwgren Board member or deputy board member
    0 SEKOption exercise
    TradedAug 23, 2018FiledAug 23, 2018
  • BioAll AB Chief executive officer
    19,200 sharesOption exercise
    TradedAug 23, 2018FiledAug 23, 2018
  • Leo Cornelis Groenewegen Chief financial officer
    5,050 sharesOption exercise
    TradedAug 23, 2018FiledAug 23, 2018